Invitae (NYSE:NVTA) Earns Sell Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Invitae (NYSE:NVTA – Get Rating) in a research note issued to investors on Thursday morning. The brokerage issued a sell rating on the medical research company’s stock. Several other research analysts also recently issued reports on NVTA. The Goldman Sachs Group downgraded shares of Invitae from a neutral rating […]

Related Keywords

San Francisco ,California ,United States ,Randalw Scott ,Robertf Werner ,Piper Sandler ,Raymond James ,Kennethd Knight ,Seane George ,Newman Schimel ,Invitae Corp ,Strategic Blueprint ,Goldman Sachs Group ,Invitae Company Profile ,Securities Exchange Commission ,Get Rating ,Stock Down ,Exchange Commission ,Aigen Investment Management ,Invitae Daily ,Invitae ,Nyse Nvta ,Nvta ,Medical ,Initiated Coverage ,Stocknews Com ,